COVID-19 and pediatric inflammatory bowel disease: How to manage it?

Area of Science:

• Pediatric gastroenterology
• Infectious disease epidemiology
• Public health

Background:

• Patients with inflammatory bowel disease (IBD) require careful management during the COVID-19 pandemic.
• There is a need for clear guidelines for pediatric IBD care amidst the pandemic.
• Caregivers and healthcare providers are seeking information on managing IBD patients during the pandemic.

Purpose of the Study:

• To synthesize current literature on managing pediatric inflammatory bowel disease (IBD) patients during the COVID-19 pandemic.
• To provide evidence-based recommendations for pediatric gastroenterologists.
• To address the specific challenges of managing pediatric IBD during the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) outbreak.

Main Methods:

• Literature review and synthesis of existing recommendations.
• Adaptation of international guidelines to national healthcare realities.
• Focus on prophylactic measures and risk assessment for SARS-CoV-2 infection in pediatric IBD patients.

Main Results:

• Key recommendations for preventing SARS-CoV-2 infection in pediatric IBD patients.
• Strategies for managing IBD treatment and maintaining remission during the pandemic.
• Guidance on risk stratification and patient-specific care.

Conclusions:

• Effective management of pediatric IBD during the COVID-19 pandemic requires a proactive approach.
• Collaboration between pediatric gastroenterologists, families, and caregivers is crucial.
• Adherence to updated guidelines is essential for patient safety and disease control.